Novavax Other Liab vs Capital Surpluse Analysis

0A3S Stock

11.90 3.06 34.62%

Novavax financial indicator trend analysis is infinitely more than just investigating Novavax recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novavax is a good investment. Please check the relationship between Novavax Other Liab and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Other Liab vs Capital Surpluse

Other Liab vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novavax Other Liab account and Capital Surpluse. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Novavax's Other Liab and Capital Surpluse is -0.7. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Novavax, assuming nothing else is changed. The correlation between historical values of Novavax's Other Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Novavax are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Other Liab i.e., Novavax's Other Liab and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

-0.7

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Other Liab

Capital Surpluse

Most indicators from Novavax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.Selling General Administrative is likely to gain to about 175.4 M in 2024

Novavax fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Other Current Assets	Other Stockholder Equity	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Cash	Long Term Debt	Cash And Short Term Investments	Good Will	Short Term Investments	Capital Surpluse	Total Liab	Treasury Stock	Intangible Assets	Inventory
Other Current Liab		1.0	0.99	-0.73	-0.98	0.96	0.98	0.62	0.29	0.9	-0.58	0.96	0.59	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	-0.66	0.66	-0.66	0.78
Total Current Liabilities	1.0		0.99	-0.74	-0.98	0.98	0.99	0.64	0.28	0.88	-0.59	0.98	0.54	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69	0.68	-0.69	0.81
Other Liab	0.99	0.99		-0.82	-0.96	0.97	0.99	0.55	0.15	0.83	-0.54	0.95	0.47	-0.7	-0.7	-0.7	-0.7	-0.7	-0.7	-0.7	-0.7	-0.7	-0.7	0.69	-0.7	0.82
Net Tangible Assets	-0.73	-0.74	-0.82		0.73	-0.73	-0.77	-0.11	0.4	-0.47	0.3	-0.66	-0.04	0.51	0.51	0.51	0.51	0.51	0.51	0.51	0.51	0.51	0.51	-0.53	0.51	-0.73
Retained Earnings	-0.98	-0.98	-0.96	0.73		-0.96	-0.97	-0.65	-0.31	-0.91	0.65	-0.95	-0.57	0.56	0.56	0.56	0.56	0.56	0.56	0.56	0.56	0.56	0.56	-0.59	0.56	-0.82
Accounts Payable	0.96	0.98	0.97	-0.73	-0.96		0.98	0.67	0.23	0.82	-0.58	0.99	0.4	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	0.75	-0.75	0.89
Other Assets	0.98	0.99	0.99	-0.77	-0.97	0.98		0.58	0.19	0.84	-0.63	0.97	0.47	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71	0.71	-0.71	0.84
Other Current Assets	0.62	0.64	0.55	-0.11	-0.65	0.67	0.58		0.73	0.78	-0.3	0.73	0.49	-0.3	-0.3	-0.3	-0.3	-0.3	-0.3	-0.3	-0.3	-0.3	-0.3	0.49	-0.3	0.66
Other Stockholder Equity	0.29	0.28	0.15	0.4	-0.31	0.23	0.19	0.73		0.58	-0.27	0.33	0.77	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	-0.02	0.03	0.02
Total Current Assets	0.9	0.88	0.83	-0.47	-0.91	0.82	0.84	0.78	0.58		-0.59	0.85	0.78	-0.34	-0.34	-0.34	-0.34	-0.34	-0.34	-0.34	-0.34	-0.34	-0.34	0.5	-0.34	0.67
Common Stock	-0.58	-0.59	-0.54	0.3	0.65	-0.58	-0.63	-0.3	-0.27	-0.59		-0.58	-0.5	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	-0.35	0.34	-0.44
Property Plant Equipment	0.96	0.98	0.95	-0.66	-0.95	0.99	0.97	0.73	0.33	0.85	-0.58		0.46	-0.74	-0.74	-0.74	-0.74	-0.74	-0.74	-0.74	-0.74	-0.74	-0.74	0.73	-0.74	0.86
Net Receivables	0.59	0.54	0.47	-0.04	-0.57	0.4	0.47	0.49	0.77	0.78	-0.5	0.46		-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06	0.07	-0.06	0.07
Total Assets	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06		1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	-0.8	1.0	-0.57
Short Long Term Debt Total	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0		1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	-0.8	1.0	-0.57
Total Stockholder Equity	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0		1.0	1.0	1.0	1.0	1.0	1.0	1.0	-0.8	1.0	-0.57
Cash	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0		1.0	1.0	1.0	1.0	1.0	1.0	-0.8	1.0	-0.57
Long Term Debt	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0		1.0	1.0	1.0	1.0	1.0	-0.8	1.0	-0.57
Cash And Short Term Investments	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0	1.0		1.0	1.0	1.0	1.0	-0.8	1.0	-0.57
Good Will	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0	1.0	1.0		1.0	1.0	1.0	-0.8	1.0	-0.57
Short Term Investments	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0	1.0	1.0	1.0		1.0	1.0	-0.8	1.0	-0.57
Capital Surpluse	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0		1.0	-0.8	1.0	-0.57
Total Liab	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0		-0.8	1.0	-0.57
Treasury Stock	0.66	0.68	0.69	-0.53	-0.59	0.75	0.71	0.49	-0.02	0.5	-0.35	0.73	0.07	-0.8	-0.8	-0.8	-0.8	-0.8	-0.8	-0.8	-0.8	-0.8	-0.8		-0.8	0.77
Intangible Assets	-0.66	-0.69	-0.7	0.51	0.56	-0.75	-0.71	-0.3	0.03	-0.34	0.34	-0.74	-0.06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	-0.8		-0.57
Inventory	0.78	0.81	0.82	-0.73	-0.82	0.89	0.84	0.66	0.02	0.67	-0.44	0.86	0.07	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57	0.77	-0.57

Click cells to compare fundamentals

Novavax Account Relationship Matchups

Novavax fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	1.7M	278.3M	1.4B	1.3B	1.5B	1.5B
Total Current Liabilities	25.8M	579.7M	2.4B	2.5B	2.8B	3.0B
Other Liab	12.6M	3.4M	175.5M	185.0M	212.8M	223.4M
Net Tangible Assets	(242.8M)	486.1M	(483.2M)	(760.4M)	(684.4M)	(650.1M)
Retained Earnings	(1.4B)	(1.9B)	(3.6B)	(4.3B)	(3.8B)	(3.7B)
Accounts Payable	2.9M	54.3M	127.1M	216.5M	249.0M	261.4M
Other Assets	7.5M	5.4M	24.3M	28.5M	32.7M	34.4M
Other Current Assets	7.3M	103.5M	56.1M	86.7M	99.7M	58.3M
Other Stockholder Equity	(12.5M)	7.0M	(1.4M)	(6.4M)	(7.3M)	(7.7M)
Total Current Assets	97.2M	1.2B	2.2B	1.7B	2.0B	1.0B
Common Stock	324K	714K	764K	868K	781.2K	813.2K
Property Plant Equipment	11.4M	187.7M	265.9M	400.5M	460.6M	483.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novavax Other Liab vs Capital Surpluse Analysis

Other Liab vs Capital Surpluse

Other Liab vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Other Liab

Capital Surpluse

Novavax fundamental ratios Correlations

Novavax Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novavax fundamental ratios Accounts

Also Currently Popular

Additional Tools for Novavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Short Long Term Debt Total	+ 1.0	Total Assets
Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets

Retained Earnings	- 0.98	Total Current Liabilities
Retained Earnings	- 0.98	Other Current Liab
Other Assets	- 0.97	Retained Earnings
Accounts Payable	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Other Liab
Property Plant Equipment	- 0.95	Retained Earnings